Eversept Partners, LP Sarepta Therapeutics, Inc. Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $10 Million - $23.4 Million	-138,644 Closed	0 $0
Q4 2020 Nov 08, 2023	BUY	$125.56 - $178.74 $17.4 Million - $24.8 Million	138,644 New	138,644 $23.6 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $17.2 Million - $24.4 Million	136,747 Added 7208.59%	138,644 $23.6 Million
Q3 2020 Nov 08, 2023	SELL	$127.12 - $172.34 $8.88 Million - $12 Million	-69,834 Reduced 97.36%	1,897 $266,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $8.88 Million - $12 Million	-69,834 Reduced 97.36%	1,897 $266,000
Q2 2020 Nov 08, 2023	SELL	$93.0 - $171.7 $304,017 - $561,287	-3,269 Reduced 4.36%	71,731 $11.5 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $6.67 Million - $12.3 Million	71,731 New	71,731 $11.5 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $6.18 Million - $9.87 Million	-75,000 Closed	0 $0
Q4 2019 Nov 08, 2023	BUY	$76.53 - $135.58 $4.47 Million - $7.92 Million	58,446 Added 353.06%	75,000 $9.68 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $5.74 Million - $10.2 Million	75,000 New	75,000 $9.68 Million
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $1.21 Million - $2.6 Million	-16,554 Closed	0 $0
Q2 2019 Nov 08, 2023	SELL	$112.21 - $151.95 $7.52 Million - $10.2 Million	-67,020 Reduced 80.19%	16,554 $2.52 Million
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $7.52 Million - $10.2 Million	-67,020 Reduced 80.19%	16,554 $2.52 Million
Q1 2019 Nov 08, 2023	BUY	$106.67 - $151.68 $4.6 Million - $6.53 Million	43,080 Added 106.39%	83,574 $9.96 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $4.6 Million - $6.53 Million	43,080 Added 106.39%	83,574 $9.96 Million
Q4 2018 Nov 08, 2023	SELL	$97.32 - $148.76 $165,444 - $252,891	-1,700 Reduced 4.03%	40,494 $4.42 Million
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $165,444 - $252,891	-1,700 Reduced 4.03%	40,494 $4.42 Million
Q3 2018 Nov 08, 2023	BUY	$115.31 - $161.51 $252,990 - $354,352	2,194 Added 5.49%	42,194 $6.81 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $252,990 - $354,352	2,194 Added 5.49%	42,194 $6.82 Million
Q2 2018 Nov 08, 2023	BUY	$71.74 - $153.69 $2.87 Million - $6.15 Million	40,000 New	40,000 $5.29 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $2.87 Million - $6.15 Million	40,000 New	40,000 $5.29 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account